In our laboratory the sensitivity of antibody (IgM vs Co-GM1 and NP-9) testing for MMN is now 85% to 90%. In general, high titers of serum IgM anti-GM1 antibodies should be detected in: 1. at least 80% of patients with multifocal motor neuropathy, and.